🇺🇸 FDA
Patent

US 11066674

Chimeric antigen receptors targeting b-cell maturation antigen

granted A61KA61K2039/505A61K48/00

Quick answer

US patent 11066674 (Chimeric antigen receptors targeting b-cell maturation antigen) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K2039/505, A61K48/00, A61P, A61P35/00